(123 days)
Not Found
No
The summary describes a dental implant system and does not mention any AI or ML components or functionalities.
Yes
The device is a medical implant intended to restore chewing function by providing permanent anchorage for prosthetic devices, which qualifies it as a therapeutic device.
No
Explanation: The device is an implant for permanent anchorage of prosthetic devices and to restore chewing function. It is not described as being used to diagnose conditions or diseases.
No
The device description clearly states it consists of physical implants, which are hardware components.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is for "surgical placement into the bone of upper /lower jaw arches as a permanent anchorage for prosthetic devices and to restore chewing function." This describes a surgical implant used in vivo (within the body) for structural support and functional restoration.
- IVD Definition: In vitro diagnostics (IVDs) are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. They are used outside the body (in vitro).
- Device Description: The device description details the physical characteristics of the implants (diameter, length), which are consistent with surgical implants, not diagnostic tests.
- Lack of IVD Indicators: The document does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological samples.
- Detecting biomarkers or analytes.
- Providing diagnostic information about a patient's health status.
- Using reagents or test kits.
This device is a surgical implant, specifically a dental implant, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Brånemark Integration AB, FIXTURE ORIGINAL is intended for surgical placement into the bone of upper /lower jaw arches as a permanent anchorage for prosthetic devices and to restore chewing function.
Product codes
DZE
Device Description
The FIXTURE ORIGINAL consists of 4 implants, diameter 3,75 mm, and length from 8,5 to 15 mm.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
bone of upper /lower jaw arches
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Mechanical testing requested for Screw-type Endosseous Implants are described in the Guideline "Information Necessary for Pre Market Notification Submission for Screw-Type Endosseous Implants", dated December 9, 1996.
Brånemark Integration AB, FIXTURE ORIGINAL is substantially equivalent to Nobel Biocare Standard Fixture in material, dimensions, and intended use why we have come to the conclusion that further testing will not raise new issues of safety and efficacy.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 872.3640 Endosseous dental implant.
(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.
0
Image /page/0/Picture/0 description: The image shows a date, "AUG 3 0 2002". The date is written in a simple, sans-serif font. The letters and numbers are all capitalized and evenly spaced. The image is clear and easy to read.
SECTION 2. SUMMARY AND CERTIFICATION
A. 510(K) SUMMARY
Summary of Safety and Effectiveness
In accordance with 21 CFR 807.92, the following information constitutes the Brånemark Integration AB summary for the FIXTURE ORIGINAL.
| SUBMITTER'S NAME: | Brånemark Integration AB |
|---|---|
| ADDRESS: | Lilla Bommen 1, SE-411 04 Göteborg, Sweden |
| CONTACT PERSON: | Rickard Brånemark |
| TELEPHONE NUMBER: | +46 (0)31 7601060 |
| FAX NUMBER: | +46 (0)31 155260 |
| DATE OF SUBMISSION: | April 22, 2002 |
1. Identification of device
Proprietary Name: Endosseous Implant Common Name: FIXTURE ORIGINAL Classification Status: Class III per regulations 872.3640 Product Codes: DZE
2. Equivalent devices
Brånemark Integration AB believes the FIXTURE ORIGINAL is substantially equivalent to Nobel Biocare AB standard fixture RP with a diameter of 3,75 mm.
3. Description of the Device
The FIXTURE ORIGINAL consists of 4 implants, diameter 3,75 mm, and length from 8,5 to 15 mm.
1
Intended use 4.
The Brånemark Integration AB, FIXTURE ORIGINAL is intended for surgical placement into the bone of upper /lower jaw arches as a permanent anchorage for prosthetic devices and to restore chewing function.
Technological characteristics, comparison to predicate device. 5.
Like the predicate devices, the FIXTURE ORIGINAL is intended to restore masticator function.
| Characteristic | Nobel Biocare Standard Fixture | Brånemarsk Integration AB FIXTURE ORIGINAL |
|---|---|---|
| Indication for use | To be placed in the upper or lower | |
| jaw to support prosthetic devices, | ||
| such as artificial teeth, and to restore | ||
| a patients chewing function. | The Brånemark Integration AB Fixture | |
| Original is intended for surgical placement | ||
| into the bone of upper /lower jaw arches as a | ||
| permanent anchorage for prosthetic devices | ||
| and to restore chewing function. | ||
| Dimensions | Diameter 3,75 mm, | |
| Length 7-20 mm | Diameter 3,75 mm | |
| Length 8,5-15 mm | ||
| 510(k) | K925765 | No number yet |
Comparison table
Discussion of performance testing. 6.
Mechanical testing requested for Screw-type Endosseous Implants are described in the Guideline "Information Necessary for Pre Market Notification Submission for Screw-Type Endosseous Implants", dated December 9, 1996.
Brånemark Integration AB, FIXTURE ORIGINAL is substantially equivalent to Nobel Biocare Standard Fixture in material, dimensions, and intended use why we have come to the conclusion that further testing will not raise new issues of safety and efficacy.
Please see section 5, Part B Performance Testing.
2
Conclusion 7.
Based on comparison to the predicate device, the Brånemark Integration AB, FIXTURE ORIGINAL, is substantially equivalent to previously cleared Nobel Biocare AB and presents no new concerns about safety and effectiveness.
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is an abstract symbol that resembles three human profiles facing right, with flowing lines beneath them.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 3 0 2002
Dr. Richard Branemark President Branemark Integration AB Lilla Bommen 1, 11 tr SE-411 04 Goteborg, SWEDEN
Re: K021355
Trade/Device Name: Fixture Original Regulation Number: 872.3640 Regulation Name: Endosseous Implant Regulatory Class: III Product Code: DZE Dated: August 5, 2002 Received: August 7, 2002
Dear Mr. Branemark:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
4
Page 2 - Dr. Branemark
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Timothy A. Ulatowski
Timothy A. Ulatowski Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
《021355
Page 1 of 1
B. INDICATIONS FOR USE
510(k) Number
Device Name: Brånemark Integration AB, FIXTURE ORIGINAL.
Indications for Use:
The Brånemark Integration AB, FIXTURE ORIGINAL is intended for surgical placement into the bone of upper /lower jaw arches as a permanent anchorage for prosthetic devices and to restore chewing function.
(Please do not write below this line - continue on another page if needed)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Prescription Use | ✓ |
|---|---|
| ------------------ | --- |
OR
Over the Counter Use
(Per 21 CFR 801.109)
Suna Runa
esthesiology, General Hospital. Infection Control. De
510(k) Number: K051235